Towards A Local Stimulation Of Natural Bypass Growth - Max Planck Scientists Developed New Treatment For Ischemic Heart Disease

Enhancing the bodies ability to create its own natural bypasses may soon become an alternative to baloon dilatation or bypass surgery. As reported in the February edition of Nature Biotechnology, scientists at the Max Planck Institute for Physiological and Clinical Research in Bad Nauheim/Germany have recently developed a non-invasive method to supply the diseased heart with vessel growth promoting factors making use of the property of microscopic beads to lodge in the peripheral vasculature. These beads are made to slowly release the growth factor without causing any damage.

Different growth factors have already been shown to promote the growth of new vessels. In particular Vascular Endothelial Growth Factor and Fibrobroblast Growth Factors have been subject to extensive research. However, whereas genes or proteins of these growth factors can simply be injected into peripheral tissues this is not possible in case of the heart. A systemic injection may also be deleterious since all of these growth factors have been shown to cause acute vascodilatation and may also promote tumor vessel growth. Attempts of vessel growth promoting therapies in the heart have therefore mainly been limited to cardiac surgery where the gene of a growth factor was given as adjunct to bypass surgery. The new method developed by Arras and collegues on the contrary requires only a routine catheterization procedure. Microscopic beads are injected into the vessel supplying the diseased territory and lodge in the peripheral capillary system whithout causing any damage. At this site they release the growth factor over a period of 7 days.

The major drawback of this method is that the growth factor will only be released within the diseased heart but not at the interface between healthy and diseased heart where large natural bypasses grow from smallest pre

Contact: Wulf D. Ito

Page: 1 2

Related biology news :

1. Towards an AIDS vaccine: unusual antibody that targets HIV described by scientists at TSRI
2. Local, regional governments could take lead in curbing global air pollution
3. Cedars-Sinai Scientists Localize New Ataxia/Epilepsy Gene
4. International Expert To Discuss Ramifications At Local Lecture...Tracking Contaminants In The Mighty Mississippi And Other Large Rivers Worldwide
5. Why Are The Fish Sick? Local Tip Suspected
6. Local Approaches To Combating Antibiotic Resistance Are Doomed To Failure
7. First Evidence That Localized Arthritis Gene Therapy Heals Distant Diseased Joints
8. Stimulation technique holds new promise for spinal cord injuries
9. Growth Factor Stimulation Leads To Increase In New Neurons In The Striatum And Cortex Of The Brain
10. Natural mineral locks up carbon dioxide
11. Naturalists of the Isthmus of Panama

Post Your Comments:

(Date:7/22/2020)... ... July 21, 2020 , ... USDM Life ... and compliance, announces a new solution to manage regulated workloads on Microsoft Azure. ... their technology stack complies with FDA and global regulations. USDM's new managed service ...
(Date:7/10/2020)... ... July 09, 2020 , ... Today CJ BIO announced the first in ... on the “fifth taste” phenomenon that is revolutionizing ingredient mixes, nutritional content and flavor ... live on Monday, July 13, 2020 at11:00 AM (CDT) during SHIFT20, the virtual edition ...
(Date:7/1/2020)... ... July 01, 2020 , ... Catalent, ... the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in Minakuchi, located in the Shiga ... supply facility located in Kakegawa, the new 60,000-square-foot facility will provide customers with ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... 29, 2020 , ... Diversified Technologies, Inc. has introduced a ... to drive Klystrons, TWTs, IOTs, and magnetrons. , DTI Radar Transmitter Systems ... a push-pull configuration; yielding fast fall time for a capacitive load. These all ...
(Date:7/31/2020)... , ... July 30, 2020 ... ... cloud-based software for the life sciences industry, today announced the release of ... designed specifically for Medical Science Liaisons (MSLs) and other field medical professionals. ...
(Date:7/18/2020)... ... , ... dicentra , a leading Contract Research Organization ... pleased to announce that Charles Galea has joined its clinical trials division as ... accomplished and results-driven sales executive with over 10 years of expertise in business ...
(Date:7/7/2020)... ... July 06, 2020 , ... R3 International is now offering stem cell therapy ... stem cells. Depending on the patient's condition, treatment may be offered IV, intrathecal or ... some form of Alzheimers dementia, and the incidence continues to increase as individuals live ...
Breaking Biology Technology:
Cached News: